Viewing Study NCT06145360

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:01 AM
Ignite Modification Date: 2026-02-09 @ 7:21 AM
Study NCT ID: NCT06145360
Status: COMPLETED
Last Update Posted: 2024-04-08
First Post: 2023-11-17
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Evaluating the Efficacy and Safety of Empagliflozin Addition to Insulin and Oral Antidiabetic Medication (OAD) Regimen in Poorly Controlled Type 2 Diabetes and Obese Patient
Sponsor: SINA Health Education and Welfare Trust
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Glucose Metabolism Disorders View
None Diabetes Mellitus, Type 2 View
None Hypoglycemic Agents View
None Empagliflozin View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Insulin Resistance View
None Type 2 Diabetes View
None Overweight View
None Add-on therapy View
None Glycemic control View